1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Albert Chiou: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 12-week Study of NFX-179 Gel in Subjects With Epidermal Nevi NFX-179 Gel 1.50% - Epidermal Nevi, Nevus Sebaceus | Phase 2 | Withdrawn | Albert Chiou | 2023-06-01 | 2024-05-28 |
Nevus, Sebaceous of Jadassohn (1)
United States (1)